Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
Browsing by Author "Aapro, Matti"
-
Rapoport, Bernardo Leon; Aapro, Matti; Paesmans, Marianne; Van Eeden, Ronwyn; Smit, Teresa; Krendyukov, Andriy; Klastersky, Jean
(BioMed Central, 2018-09-24)
BACKGROUND : Febrile neutropenia (FN) is a common occurrence during chemotherapy. Granulocyte colony-stimulating
factors (G-CSFs) can significantly reduce the risk of FN. International guidelines recommend G-CSF for ...
-
Gascón, Pere; Harbeck, Nadia; Rapoport, Bernardo Leon; Anderson, Ronald; Brueckmann, Ines; Howe, Sebastian; Aapro, Matti
(Elsevier, 2024-04)
Filgrastim is approved for several indications, including reduction of the incidence and duration of chemotherapy-induced neutropenia and for stem cell mobilization. The filgrastim biosimilar, EP2006, has been available ...
-
Aapro, Matti; Lyman, G.H.; Bokemeyer, C.; Rapoport, Bernardo Leon; Mathieson, N.; Koptelova, N.; Cornes, P.; Anderson, Ronald; Gascon, P.; Kuderer, N.M.
(Elsevier, 2021)
Cancer care has been profoundly impacted by the global pandemic of severe acute respiratory syndrome coronavirus 2 disease (coronavirus disease 2019, COVID-19), resulting in unprecedented challenges. Supportive care is an ...